Intervention
Ferric derisomaltose
ClinicalTrials.gov intervention label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov intervention label, found in 4 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
4 shownIRONHEART: Intravenous Iron in Non-ischaemic Heart FailureNCT06542822 · 2024-04-15
RECRUITINGIV Iron Therapy for Older Adults With Heart Failure With Preserved Ejection Fraction and Iron DeficiencyNCT07686692 · 2026-08-01
NOT_YET_RECRUITINGThe Effects of Ferric Derisomaltose in Patients With Acute Heart Failure and Iron Deficiency on Exercise Capacity and Quality of LifeNCT05991128 · 2023-08-01
UNKNOWNThe Effects of Ferric Derisomaltose in Patients With Acute Heart Failure and Iron Deficiency on Exercise Capacity and Quality of Life(COREVIVE-HFrEF)NCT05971732 · 2023-08-01
UNKNOWNCommon conditions
Leading sponsors
Trial status mix
UNKNOWN2
NOT_YET_RECRUITING1
RECRUITING1
Phase mix
PHASE43
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.